Donate For Public and Patients Store Search

Go to AAD Home

AAD VMX 2020 library

Interested in licensing this content?

Request .mp4 files of the session videos from the Academy's licensing team.

Submit your request

Scientific sessions

Click on the links in the bulleted lists below to view individual presentations.

Micrographic Dermatologic Surgery (MDS) Subspecialty Certification Exam Prep Course

This is a question and explanation based, session covering the subjects in the MDS Exam Review Guide to assist in preparations for the American Board of Dermatology’s MDS Subspecialty Certification Exam.

Therapeutic Hotline

This session reviews new and emerging therapeutics for patients with psoriasis, dyspigmentation, and hair diseases. The newest and what's hot in dermatology ranging from medical to cosmetic to surgical dermatology is addressed. 

JAK Inhibitors: A New Frontier in Dermatology

The recent emergence of Janus kinase (JAK) inhibitors has led to new therapeutic options in dermatology. The application of JAK inhibitors to common dermatologic diseases, with significant unmet medical need, is presented, including the results of clinical trials and case series. The audience for this session is dermatologists who care for patients with vitiligo, atopic dermatitis, psoriasis, granuloma annulare and sarcoidosis, in addition to other conditions.

Therapeutic and Diagnostic Pearls

This session highlights important diagnostic and therapeutic pearls and is directed towards both novice and experienced clinicians. Information discussed is based on both peer-reviewed literature and the result of personal experience.

What's New in Dermatology

This session reviews new developments in dermatologic surgery, cosmetic dermatology, pediatric dermatology, and medical dermatology. Specific sessions present new information from acne, rosacea, hidradenitis, and psoriasis, and there will be a session devoted to systemic dermatologic therapy.

What's New in Dermatopathology

This symposium provides information regarding advances in key areas of dermatopathology. Histopathologic findings of COVID-19, neoplastic lesions, inflammatory dermatitis, recent acceptable use criteria, molecular techniques, translational research, and viral infections are covered.

Hidradenitis Suppurativa/Acne Inversa (HS/AI): Current Medical and Surgical Management

This session reviews hidradenitis suppurativa (HS) epidemiology and comorbidities, and current concepts of pathogenesis. An evidence-based approach for the use of medical therapies for HS, including topical agents, antibiotics, non-antibiotic systemics and biologics, is discussed. An approach to HS pain management is also presented.

Skin of Color

This session provides attendees with insight into skin conditions more commonly seen in patients with skin of color and provide ways to better diagnose and manage these conditions. Disorders of pigmentation are covered. 

Hair Disorders Made Easier

This session covers the basics of the patient evaluation for hair loss, including diagnostic tips, treatment pearls, ethnic hairstyling, surgical procedures, and clinicopathologic correlation. It is directed at all practitioners who see alopecia patients.

Systemic Therapies for Dermatologists: A Comprehensive Review and Update

This session provides cutting edge information on a potpourri of topics dermatologists are going to deal with this year. Topics covered include the use of cannabinoids in dermatology; systemic medications available to treat more aggressive non melanoma skin cancers; diagnosing and managing adverse effects associated with many of these newer medications; and, how to manage pain in the post opioid era.

Making Teledermatology Work

Dermatologists have been at the forefront of telehealth for the past two decades. In light of current events, even more dermatologists are adopting telehealth services. The purpose of this webinar is to educate dermatologists on the implementation of telehealth in their practices with current regulations from the Centers for Medicare and Medicaid Services (CMS) in mind.

Late-breaking research

Late-breaking Research: Clinical Trials

For residents